M. Hirano

Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.

K. Teraoka, M. Hirano, H. Ookubo, 2004, Magnetic resonance imaging.

Association of tocilizumab treatment with changes in measures of regional left ventricular function in rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging

M. Takei, Y. Nakajima, M. Hirano, 2016, International journal of rheumatic diseases.

Left Ventricular Regional Dysfunction Using Cardiac Magnetic Resonance Imaging in Rheumatoid Arthritis Patients Without Cardiac Symptoms: Comparison Between Methotrexate and Biologics Treatment Groups

M. Hirano, Yasuyuki Kobayashi, Hitomi Kobayashi, 2014, The Journal of Rheumatology.

Progressive cardiac dysfunction in adriamycin‐induced cardiomyopathy rats

K. Teraoka, M. Hirano, A. Yamashina, 2000, European journal of heart failure.

Cost minimization analysis of beta-blocker at the time of CT imaging for suspected of coronary heart disease in Japan

M. Hirano, T. Fukuda, A. Igarashi, 2014, Journal of medical economics.

Three-dimensional T2-weighted imaging using the dark blood method for detecting pulmonary embolisms: comparison with computed tomography angiography

M. Hirano, Y. Saida, M. Matsusako, 2011, Japanese Journal of Radiology.

Radiation-Dose-Lowering Effects of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography (DELIGHT)　- A Prospective Multicenter Study.

M. Jinzaki, S. Kuribayashi, T. Kido, 2016, Circulation journal : official journal of the Japanese Circulation Society.

A Multicenter, Open-Label Study of an Intravenous Short-Acting β1-Adrenergic Receptor Antagonist Landiolol Hydrochloride for Coronary Computed Tomography Angiography by 16-Slice Multi-Detector Computed Tomography in Japanese Patients with Suspected Ischemic Cardiac Disease

M. Jinzaki, S. Kuribayashi, Y. Ikari, 2014, Drugs in R&D.